Mimoto R - Search Results

1

Diminished DYRK2 sensitizes hormone receptor-positive breast cancer to everolimus by the escape from degrading mTOR.

Mimoto R, Nihira NT, Hirooka S, Takeyama H, Yoshida K. Mimoto R, et al. Cancer Lett. 2017 Jan 1;384:27-38. doi: 10.1016/j.canlet.2016.10.015. Epub 2016 Oct 13. Cancer Lett. 2017. PMID: 27746162

2

Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer.

Mimoto R, Imawari Y, Hirooka S, Takeyama H, Yoshida K. Mimoto R, et al. Oncogene. 2017 Mar 30;36(13):1862-1872. doi: 10.1038/onc.2016.349. Epub 2016 Oct 10. Oncogene. 2017. PMID: 27721402

3

DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail.

Mimoto R, Taira N, Takahashi H, Yamaguchi T, Okabe M, Uchida K, Miki Y, Yoshida K. Mimoto R, et al. Cancer Lett. 2013 Oct 10;339(2):214-25. doi: 10.1016/j.canlet.2013.06.005. Epub 2013 Jun 18. Cancer Lett. 2013. PMID: 23791882

4

DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma.

Yamaguchi N, Mimoto R, Yanaihara N, Imawari Y, Hirooka S, Okamoto A, Yoshida K. Yamaguchi N, et al. Among authors: mimoto r. Tumour Biol. 2015 Aug;36(8):5913-23. doi: 10.1007/s13277-015-3264-y. Epub 2015 Feb 25. Tumour Biol. 2015. PMID: 25712377

5

Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer.

Ito D, Yogosawa S, Mimoto R, Hirooka S, Horiuchi T, Eto K, Yanaga K, Yoshida K. Ito D, et al. Among authors: mimoto r. Cancer Sci. 2017 Aug;108(8):1565-1573. doi: 10.1111/cas.13280. Epub 2017 Jun 19. Cancer Sci. 2017. PMID: 28502078 Free PMC article.

6

Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer.

Imawari Y, Mimoto R, Hirooka S, Morikawa T, Takeyama H, Yoshida K. Imawari Y, et al. Among authors: mimoto r. Cancer Sci. 2018 Feb;109(2):363-372. doi: 10.1111/cas.13459. Epub 2018 Jan 13. Cancer Sci. 2018. PMID: 29193658 Free PMC article.

7

DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells.

Taira N, Mimoto R, Kurata M, Yamaguchi T, Kitagawa M, Miki Y, Yoshida K. Taira N, et al. Among authors: mimoto r. J Clin Invest. 2012 Mar;122(3):859-72. doi: 10.1172/JCI60818. Epub 2012 Feb 6. J Clin Invest. 2012. PMID: 22307329 Free PMC article.

8

Clinical relevance and low tumor-initiating properties of oligometastatic breast cancer in pulmonary metastasectomy.

Mimoto R, Kobayashi T, Imawari Y, Kamio M, Kato K, Nogi H, Toriumi Y, Hirooka S, Uchida K, Takeyama H. Mimoto R, et al. Breast Cancer Res Treat. 2014 Sep;147(2):317-24. doi: 10.1007/s10549-014-3111-7. Epub 2014 Aug 26. Breast Cancer Res Treat. 2014. PMID: 25156580

9

Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy.

Nogi H, Uchida K, Mimoto R, Kamio M, Shioya H, Toriumi Y, Suzuki M, Nagasaki E, Kobayashi T, Takeyama H. Nogi H, et al. Among authors: mimoto r. Clin Breast Cancer. 2017 Dec;17(8):644-649. doi: 10.1016/j.clbc.2017.05.002. Epub 2017 May 8. Clin Breast Cancer. 2017. PMID: 28601382 Free article.

10

Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cells.

Mimoto R, Yogosawa S, Saijo H, Fushimi A, Nogi H, Asakura T, Yoshida K, Takeyama H. Mimoto R, et al. Sci Rep. 2019 Sep 16;9(1):13405. doi: 10.1038/s41598-019-49775-w. Sci Rep. 2019. PMID: 31527634 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters